Moderna's mRNA flu vaccine approved by FDA. When is it available?

Live updates

1. 18d ago

   FDA approves Moderna mRNA flu vaccine for adults 50 plus

   The FDA has cleared Moderna's first mRNA influenza vaccine for adults aged 50 and older. The vaccine is intended for use ahead of the 2026-27 season and demonstrated 27% higher efficacy than standard flu shots. While Moderna targets a quick rollout, specific distribution dates for the general public are not yet detailed. This approval coincides with the FDA's recent authorization of updated COVID-19 vaccines for the same season to address current viral strains.

   Why it matters

   This marks the first time mRNA technology, previously used for COVID-19, is applied to prevent influenza. The timing aligns with the typical autumn spike in respiratory diseases.

   What is confirmed

   • The FDA cleared Moderna's first mRNA flu vaccine for adults aged 50 and older.
   • The mRNA flu vaccine showed 27% higher efficacy than standard shots.

   Still unconfirmed

   • Moderna targets a quick rollout of the mRNA flu vaccine.

   What to watch next

   • Official distribution dates and pharmacy availability for the 2026-27 flu season.
   • Clinical data on mRNA flu vaccine efficacy for adults under 50.
   Sources used for this update (6)

   1. indiawest.com — FDA Clears First mRNA Flu Vaccine, Moderna Targets Quick Rollout
   2. abcnews.com — FDA approves updated COVID vaccines. Here's what you need to know
   3. www.usatoday.com — FDA approves updated COVID vaccines for 2026-27 season
   4. TribLIVE.com — 5 things to know about the newly approved covid-19 vaccines
   5. www.usatoday.com — Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
   6. www.cidrap.umn.edu — Quick takes: Infant botulism, New World screwworm preventative, ‘airport malaria’ in Germany, new polio cases in Africa
   confidence 90%
2. 22d ago

   FDA approves Moderna mRNA flu vaccine

   The FDA has approved a new mRNA flu vaccine developed by Moderna. This vaccine is available for older adults this year. While the approval marks a shift in influenza prevention technology, specific distribution dates and wide-scale availability details remain limited in current reports. The product represents the first application of mRNA technology for flu prevention following the success of COVID-19 vaccines.

   Why it matters

   Traditional flu shots typically use inactivated viruses or proteins. mRNA vaccines provide a different mechanism for triggering immune responses. This approval allows Moderna to expand its product line beyond COVID-19.

   What is confirmed

   • The FDA approved Moderna's mRNA flu vaccine.
   • A new type of flu vaccine for older adults is available this year.

   What to watch next

   • Public release dates for general populations
   • Clinical efficacy data compared to traditional flu shots
   Sources used for this update (5)

   1. Times Union — There’s a new type of flu vaccine for older adults this year. Can you get it?
   2. Medical News Today — New flu vaccine: Moderna's mRNA vaccine approved by FDA
   3. Yahoo Finance — Moderna's Comeback Is Finally Taking Shape -- and There May Be More Upside Ahead
   4. UC Santa Cruz - News — RNA researcher on the basics of how mRNA vaccines are made and work
   5. Medical Professionals Reference — Navigating the New mRNA Flu Shot: A Discussion With Dr William Schaffner
   confidence 90%